Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy — Stella

Home/Cardiomyopathy, Hypertrophic/Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy

View on ClinicalTrials.gov

Recruiting

Back to Cardiomyopathy, Hypertrophic trials

Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Germany

Technical University Munich, Munich, Bavaria

Key details

Sponsor

Technical University of Munich

Enrollment target

~24 participants

Started

November 2025

Primary completion

October 2026

Age range

18 Years – 99 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.